Association of late-onset neonatal sepsis with late neurodevelopment in the first two years of life of preterm infants with very low birth weight

Abstracts

OBJECTIVE:

To establish the influence of late-onset sepsis on neurodevelopment of preterm infants with very low birth weight (VLBW), according to the etiologic agent

METHOD:

This was a cohort of newborns with birth weight < 1,500 g and gestational age less than 32 weeks, admitted to the institutional intensive care unit (ICU) with up to 48 hours of life, and followed-up at the outpatient follow-up clinic for preterm infants with VLBW until 2 years of corrected age. Exclusion criteria: death within the first 72 hours of life, congenital malformations and genetic syndromes, children with congenital infection by the human immunodeficiency virus (HIV), congenital infection (STORCH), presence of early-onset spesis and cases with more than one pathogen growth in blood cultures. Septic and non-septic infants were compared regarding neonatal outcomes and mortality. Neurodevelopment was assessed using the Bayley Scale (BSDI-II) at 18 to 24 months of corrected age.

RESULTS:

411 preterm infants with VLBW were eligible; the mean gestational age was 29 ± 2.2 weeks and mean birth weight was 1,041 ± 281grams. Late-onset sepsis occurred in 94 preterm infants with VLBW (22.8%). VLBW infants with Gram-positive infection showed motor deficit when compared to the non-septic group, 68.8% vs. 29.3%, respectively (OR 6; 1.6-21.8, p = 0.006); the cognitive development was similar between the groups. The overall mortality rate from infection was 26.7%; considering the pathogens, the rates were 18.7% for coagulase-negative Staphylococcus, 21.8% for Gram-positive bacteria, and 50% for Gram-negative bacteria and fungi.

CONCLUSION:

Neonatal sepsis has a significant influence on late neurodevelopment at 2 years of corrected age in preterm infants with VLBW, and Gram-positive infections are associated with motor deficit.

Preterm; Very low birth weight; Neonatal sepsis; Mortality; Neurodevelopment

OBJETIVO:

Estabelecer a influência da sepse tardia no neurodesenvolvimento de prematuros de muito baixo peso (MBP) recém-nascidos (RNs) de acordo com o agente etiológico.

MÉTODOS:

Coorte de RN com peso de nascimento < 1.500 g e idade gestacional < 32 semanas,internados na UTI da instituição dentro de 48 horas de vida, e atendidos no ambulatório de MBP para até dois anos de idade corrigida. Foram excluídos: a morte nas primeiras 72 h de vida, malformações congênitas e síndromes genéticas, filhos de mães HIV-positivas e infecção congênita, presença de sepse precoce, e os casos com mais de um microorganismo identificado em hemoculturas. RNs sépticos e não sépticos foram comparados quanto resultados neonatais, mortalidade e neurodesenvolvimento avaliados através das escalas Bayley (BSDI-II) aos 18-24 meses de idade corrigida.

RESULTADOS:

Um total de 411 RNs prematuros de muito baixo peso eram elegíveis, com idade gestacional = 29 ± 2,2 semanas e peso de nascimento = 1.041 ± 281 g. Sepse tardia ocorreu em 94 casos (22,8%). MBP RN com infecção causada por microrganismos Gram-positivos apresentaram atraso motor, quando comparado com o grupo sem sépsis - 68,8% vs 29,3% (OR 6; 1,6-21,8,p = 0,006), e atraso cognitivo, foi semelhante. Taxa de mortalidade global de infecção foi de 26,7%, e as taxas de mortalidade por grupo microorganismo foram: Staphylococcus coagulase negativa, 18,7%; Gram-positivos, 21,8%; Gram-negativas e fungos, 50%.

CONCLUSÃO:

A sepse neonatal tem uma influência significativa no atraso no desenvolvi mento neuropsicomotor aos dois anos de idade corrigida em prematuros de muito baixo peso RN e as infecções por germes gram-positivos estão associadas com atraso motor.

Prematuros; Muito baixo peso ao nascer; Sepse neonatal; Mortalidade; Neuro-desenvolvimento

Introduction

The higher survival rate of preterm infants with very low birth weight (VLBW) in recent decades has not been accompanied by a reduction in the number of serious morbidities in neonatal intensive care units (ICUs) and during followup after discharge. In addition to minor morbidities, severe neurodevelopmental disorders and/or cerebral palsy are significant, with high economic and social costs, particularly in less developed countries.¹

The association of neonatal sepsis with the increased risk of neurodevelopmental disorders in this population, especially learning difficulties, cognitive impairment, cerebral palsy, and visual and auditory deficits, has been a subject of interest in developed countries.^{1 - 3}

Bacterial and fungal infections remain a major cause of neonatal morbidity and mortality. Approximately 21% of preterm infants with VLBW have late-onset sepsis, with high mortality rates, mainly caused by Gram-negative infections.⁴ However, data on the follow-up of preterm infants with late-onset sepsis are underexplored. Therefore, this study aimed to establish the influence of late-onset sepsis, according to the etiologic agent, on the neurodevelopment and mortality of preterm infants with VLBW.

Method

This was a prospective cohort study conducted from November, 2003 to May, 2010, which included newborns with VLBW (birth weight < 1,500 g and gestational age less than 32 weeks), admitted to the institutional ICU with up to 48 hours of life and followed at the outpatient follow-up clinic for preterm infants with VLBW. The study was approved by the Research Ethics Committee of the Hospital de Clínicas de Porto Alegre, under registration number 10-0300. Parents or guardians of the study participants signed an informed consent.

Exclusion criteria were deaths within the first 72 hours of life, congenital malformations and genetic syndromes, children with congenital infection by the human immunodeficiency virus (HIV), congenital infection (STORCH), newborns with early-onset sepsis and more than one pathogen growth in blood cultures. Patients included in the study were divided into two groups, according to the presence or absence of late-onset sepsis, defined as the presence of positive blood cultures over 72 hours of life,^{5 , 6} followed by clinical signs (changes in breathing pattern, hypothermia or hyperthermia, circulatory symptoms, gastrointestinal symptoms). All blood cultures throughout hospitalization were reviewed, and the patients of the non-septic group had negative blood cultures. Positive blood cultures for bacteria considered contaminants were excluded, including Bacillus sp., Micrococcus sp., and Bacteroides sp., in accordance with the criteria of the Brazilian Health Surveillance Agency (Agência Nacional de Vigilância Sanitária ANVISA).⁷ In cases of a blood culture positive for coagulase-negative Staphylococcus (CNS), only newborns whose clinical and laboratory findings were consistent with sepsis (leukocytosis and/or leukopenia and/or increased C-reactive protein) were included in the sepsis group.⁸

Table 1
Characteristics of preterm infants with very low birth weight according to the presence of late-onset sepsis.

	Late-onset sepsis (94)	No late-onset sepsis (317)		p
Birth weighta (g)	1,024 ± 228	1,078 ± 282		0.058
Gestational age	29.06 ± 1.84	29.28 ± 2.21		0.38
Maleb	48.9% (46)	45.7%	(145)	0.61
Antenatal steroids	62.7% (59)	60.2%	(191)	0.93
APGAR score at 5 minutesc	8 (7-9)	8 (7-9)		0.99
Oxygen time	6 (0-18.25)	2 (0-10)		0.005
CPAP time	5 (2-15)	2 (0-5)		< 0.001
MV time	6 (1-27)	4 (0-11)		0.02
Bronchopulmonary dysplasia	36.2% (34)	16.7%	(53)	< 0.001
RBC transfusion	83% (78)	68.8%	(218)	0.009
Intaventricular hemorrhage grades 3 and 4	14% (13)	12.7%	(38)	0.54
Leukomalacia	23.7% (22)	17% (51)		0.17
Seizure	44.7% (42)	22.7%	(72)	< 0.001
ROP grades 3 and 4	5.3% (5)	1.89%	(6)	0.13
Hospitalization (days)	62 (43.5-81.5)	42 (30-56)		< 0.001
Death at neonatal ICU	24.5% (23)	28.7%	(91)	0.55
Death at follow-up	2.8% (2)	1.8% (4)		0.63
Cognitive impairment	85.9 (±10.8)	86.1 (±11.59)		0.79
Motor deficit	89.8 (±13.3)	91.65 (±14.02)		0.28

• ^CPAP
  , continuous positive airway pressure
• ^MV
  , mechanical ventilation
• ^RBC
  , red blood cell
• ^ROP
  , retinopathy of prematurity
• ^a
  Student's t-test for independent samples.
• ^b
  Chi-squared test.
• ^c
  Mann-Whitney test.

The following data were collected and compared between both groups: use of antenatal corticosteroids; preeclampsia; gender; gestational age (GA) determined by obstetric GA, in cases of obstetric ultrasound in the first 12 weeks of pregnancy, or by pediatric GA, using the Ballard method;⁹ birth weight, using the classification by weight and GA: small for GA (SGA), appropriate for GA (AGA), and large for GA (LGA), in accordance with Alexander's curve;¹⁰ type of delivery; APGAR score at 5 minutes; SNAPPE II score (Score for Neonatal Acute Physiology-Perinatal Extension-II); length of hospital stay; intraventricular hemorrhage; and periventricular leukomalacia. In cases of intraventricular hemorrhage, the diagnosis was performed using cranial ultrasound, and only cases with grade 3 and 4 on the Papile classification were considered for statistical analysis, due to their association with developmental disorders.¹¹ Ventilatory support; hyaline membrane disease (HMD); bronchopulmonary dysplasia (BPD), defined as oxygen dependency at 28 days of life;¹² patent ductus arteriosus (PDA) diagnosed by echocardiography; severe retinopathy of prematurity, grades 3 and 4 (ROP 3-4) according to the international classification; neutropenia; transfusion of packed red blood cells; and seizures were also assessed.

During outpatient follow-up, neurodevelopment at 18 and 24 months of corrected age was evaluated using the Bayley Scales of Infant and Toddler Development II (BSDI-II). The psychologist was blinded to the groups during this evaluation. Scale applications were performed in the outpatient follow-up on the same day of the routine visit. The cognitive/mental scores assessed by the Mental Developmental Index (MDI) and Psychomotor Developmental Index (PDI) were considered normal for results greater than or equal to 85, moderate for results between 70-84, and severe for results less than or equal to 69.¹³ Cases of blindness, deafness, and cerebral palsy in premature infants with VLBW, whom the application of Bayley Scales (MDI and PDI) is not adequate, were considered as severe late neurodevelopment.

The primary outcomes assessed were death during neonatal hospitalization and outpatient follow-up, and diagnosis of late neurodevelopment, overall and according to the pathogens identified in blood cultures after 72 hours of life.

Statistical analysis

The estimated sample size was based on the incidence of neurological events found in the group with clinical sepsis of a major multicenter study,¹⁴ which evaluated VLBW newborns stratified into different categories of infection, with a sample size of 124 patients in the non-sepsis group and 31 patients with neonatal sepsis, in order to detect a twofold risk of higher neurological outcomes in the sepsis group compared to the group unexposed to the risk factor, considering an alpha error of 0.05 and 80% power.

Figure 1
Flowchart of the cohort of very low birth weight preterm newborns (VLBW).

In multivariate analysis, the variables selected for control were those with statistically significant difference or slightly higher than 0.05 in univariate analysis, when compared with the groups with and without neurological outcomes. Logistic regression was performed for each group of neurological outcome and considering each sepsis group by pathogen.

The Statistical Package for Social Science (SPSS) version 18.0 was used for analysis. The chi-squared test, Student's ttest, Mann-Whitney test, and logistic regression were used, considering p < 0.05 as significant.

Results

A total of 411 preterm infants with VLBW were consecutively admitted. Mean GA was 29 ± 2.2 weeks and mean birth weight 1,041 ± 281 grams, with predominance of the female gender (53.5%). Late-onset sepsis was present in 94 preterm infants with VLBW, an incidence of 22.8%. VLBW infants with late-onset sepsis were sicker; required longer mechanical ventilation support and hospital stay; and had higher incidence of bronchopulmonary dysplasia, seizures, and transfusion of packed red blood cells (Table 1).

The death rate of patients included in the study was 28% (n = 114) in the neonatal ICU, and 1.5% (n = 6) in the outpatient clinic. Neurodevelopmental evaluation using the BSDI-II was performed on 213 patients; 90% of the sepsis and 74% of the non-sepsis groups (Fig. 1). Thirteen patients had very serious impairment, which prevented the execution of tasks during BSDI-II application due to blindness (n = 3), deafness (n = 3), and cerebral palsy (n = 7), and were included in the group with severe neurodevelopmental impairment for analysis.

Sixty-eight infants (30%) had late motor development, of whom 22 (9.7%) were in the non-sepsis group. Changes in muscle tone were identified in 24 infants. Hypertonia was the most frequent dysfunction (17 evaluated as hypertonic and seven as hypotonic), mainly affecting the upper and/or lower limbs, or one hemisphere. In ten infants, four cases of left spastic hemiparesis, four cases of spastic quadriparesis, and two cases of spastic diparesis were identified.

Table 2
Neurodevelopmental follow-up of very low birth weight preterm infants according to the infectious agent.

		CNS (n = 36)		Non-septic (n = 155)	p
PDI a		93	± 12.49b	91.65 ± 14.02	0.6
MDI		87.45	± 10.75	86.11 ± 11.59	0.5
		Gram-positive (n = 13)		Non-septic (n = 155)
PDI		83.54	± 13.67	91.65 ± 14.02	0.047
MDI		84.85	± 12.02	86.11 ± 11.59	0.7
		Gram-negative and fungi (n = 9)		Non-septic (n = 155)
PDI		85.67	± 16.52	91.65 ± 14.02	0.22
MDI		80.89	± 10.27	86.11 ± 11.59	0.18
		CNS (n = 36)		Non-septic (n = 164)
Cognitive impairment		17 (47.2%)c		76 (46.3%)	1
Motor deficit		6 (16.7%)		48 (29.3%)	0.18
		Gram-positive (n = 16)		Non-septic (n = 164)
Cognitive impairment		12 (75%)		76 (46.3%)	0.054
Motor deficit		11 (68.8%)		48 (29.3%)	0.003
		Gram-negative and fungi (n = 10)		Non-septic (n = 164)
Cognitive impairment		5 (50%)		76 (46.3%)	1
Motor deficit		4 (40%)		48 (29.3%)	0.71

• ^CNS
  , coagulase negative Staphylococcus
• ^MDI
  , Mental Development Index
• ^PDI
  , Physical Development Index.
• ^a
  Bayley Scales of Infant and Toddler Developmental II.
• ^b
  Student's t-test for independent samples.
• ^c
  Absolute and relative frequencies, chi-squared test.

Among VLBW preterm infants with higher motor impairment, deficits in gross motor developmental milestones were identified, such as trunk and head support, as two children did not acquire cervical control and two did not achieve the sitting position independently at 24 months of age. Another important functional limitation in gross motility refers to independent walking, which was not achieved by 12 children at 24 months of age; in eight of these, walking was only possible with the use of support (help from others and/or baby walker). Among those who walked independently, atypical patterns were observed in ten cases: hemiplegic gait (n = 3), unsteady gait and an increase in the support polygon (n = 3), valgus feet (n = 2), digitigrade gait (n = 1), and scissor gait (n = 1). reeling gait'' e ''pes valgus.

The microorganisms found were CNS (n = 44; 46.8%), S. aureus (n = 22; 23.4%), Candida (n = 11; 12%), Klebsiella (n = 6; 6.4%), Enterobacter (n=2; 2%), Pseudomonas (n=2; 2%), Streptococcus agalactiae (n=2; 2%), E. coli (n=1; 1%), Enterococcus (n=1; 1%), Streptococcus viridans (n=1; 1%), Acinetobacter (n=1; 1%), Cepacia (n = 1; 1%), and S. epidermidis (n = 1; 1%). For analysis, patients were grouped into ''Gram-positive sepsis'', ''CNS sepsis'', and ''Gramnegative and fungi sepsis''.

Infection caused by Gram-negative bacteria and fungi presented the worst results when the death or severe motor deficit outcome was analyzed: 10.7% of the patients with this outcome had sepsis caused by Gram-negative bacteria, versus 4.5% of patients without this outcome (p = 0.046); however, this difference was not maintained in the multivariate analysis (OR 3.76; 0.77-18.30; p = 0.1); lower GA and duration of hospital stay were the main risk factors. Infection by Gram-positive bacteria showed motor deficit among VLBW preterm infant survivors (68.8% vs. 29.3%), while cognitive development was similar (Table 2). This result was maintained in the multivariate analysis, where an association between motor deficit and Gram-positive sepsis was observed (OR 6; 1.6-21.8, p = 0.006) (Table 3), adjusted for type of delivery, maternal pre-eclampsia, use of antenatal corticosteroids, packed red blood cell transfusions, leukomalacia, ROP, SNAPPE II, duration of hospitalization, and GA; these factors are known to be associated with late neurodevelopment.

Overall mortality secondary to infection accounted for 26.7% of deaths; stratifying by pathogen, the percentages were: 18.7% in the CNS group, 21.8% in the Gram-positive group, and 50% in the Gram-negative and fungi group.

Discussion

The present study reinforced the finding that late-onset of neonatal sepsis is associated with late neurodevelopment in the first 2 years of life in preterm infants with VLBW. Previous studies have suggested that infants with signs of sepsis were more likely to have cerebral palsy, lower cognitive and motor scores, and visual impairment.¹⁴ In this study, the particular involvement of Gram-positive infection, which presented a six-fold higher risk for motor deficit in this population, was emphasized.

Table 3
Neurodevelopment at 2 years of corrected age by group of pathogens in septic neonates -multivariate analysisa

			Other Gram-positive pathogens								Coagulase-negative Staphylococcus							Gram-negative bacteria and fungi
		Crude OR (CI)		p	Adjusted OR (CI)		p		Crude OR (CI)			p	Adjusted OR (CI)	p		Crude OR (CI)			p	Adjusted OR (CI)		p
Severe motor	3.6		(1.02-12)	0.046	4.1	(0.88-19)	0.071		0.6		(0.1-2.7)	0.5	0.6 (0.1-4.1)	0.68		4.2		(0.9-18)	0.051	1.3	(0.2-8)	0.74
deficit
Severe and	4.8		(1.5-14.8)	0.006	6	(1.6-21)	0.006		0.4		(0.1-1.1)	0.076	0.5 (0.1-1.6)	0.24		1.6		(0.4-5.9)	0.47	0.8	(0.1-3.9)	0.8
moderate motor
deficit
Severe cognitive	2		(0.5-7.8)	0.30	1.9	(0.4-8.9)	0.39		0.5		(0.1-2.2)	0.35	0.9 (0.1-5.6)	0.99		2		(0.4-10)	0.39	1.5	(0.2-10.2)	0.67
impairment
Severe and	3.1		(0.9-10.4)	0.055	3.9	(0.96-16)	0.06		0.9		(0.4-2)	0.94	0.9 (0.3-2.4)	0.91		1.1		(0.3-4.1)	0.82	0.3	(0.03-3)	0.33
moderate

• ^CHAD
  , Concentrado de hemácias de adultos
• ^CI
  , confidence interval
• ^OR
  , odds ratio
• ^SNAPPE
  , Score for Neonatal Acute Physiology-Perinatal Extension-II.
• ^a
  Logistic regression adjusted for type of delivery, maternal preeclampsia, use of antenatal corticosteroids, CHAD transfusion, leukomalacia, retinopathy of prematurity, length of stay,SNAPPE II, Gestational Age

Some hypotheses have been suggested to justify late neurodevelopment in newborns with sepsis, particularly early-onset sepsis. The most accepted theories associate systemic inflammatory response (with cytokine and free radical activation) with subsequent white matter damage, probably due to astrogliosis, and loss of preoligodendrocytes.⁸ The association of late-onset sepsis with unfavorable neurodevelopmental outcomes may be explained as a result of this systemic inflammatory response, increasing comorbidities associated with worse outcomes (such as hypotension, disseminated intravascular coagulation, chronic lung disease, and severe intraventricular hemorrhage) and death.²

In the present study, late-onset sepsis was detected in 22.8% of the VLBW preterm infants, similar to previous studies,^{2 , 15} as well as the predominance of Gram-positive organisms (70.2%) and the most common CNS pathogen (46.8% of all sepsis cases, 66.6% of Gram-positive infections). These findings are also very close to those of a large study conducted by the National Institute of Child Health and Human Development (NICHD) Neonatal Research Network, which observed that 70% of infections were caused by Gram-positive bacteria, and CNS accounted for 48% of infections and 68% of Gram-positive infections.¹⁶

Among VLBW preterm infants with late-onset sepsis followed-up for up to 24 months of corrected age, 6.1% had severe neurodevelopmental impairment and 3.2% had cerebral palsy. The mortality rates from sepsis and pathogens (26.7% overall mortality, 18.7% in the CNS group, 21.8% in the Gram-positive group, and 50% in the Gram-negative and fungi group) in the present study are in agreement with those observed by Stoll et al.¹⁶ (mortality rate due to sepsis, 18%; to CNS, 9%; to other Gram-positive bacteria, 11.2%; to Gram-negative bacteria 36%; and to fungi, 32%). This demonstrates that infection indicators from major international centers may be applied in the Brazilian setting.

There are conflicting data for CNS infection as a risk factor for late neurodevelopment.^{8 , 15} In the present study, no differences were observed in cognitive and motor scores for newborns who presented with late-onset sepsis by CNS, similarly to a previous study.⁸ Therefore, it was decided to evaluate the newborns who presented sepsis for Gram-positive infection, excluding CNS; in this scenario, a significant motor deficit was observed, even after controlling for variables such as intraventricular hemorrhage and leukomalacia. Schlapbach et al.¹⁵ found a two-fold higher risk of late neurodevelopment in the presence of sepsis caused by other Gram-positive bacteria.

In the present study, the mortality rate due to Gramnegative bacteria and fungal infection was 50%. Previous studies also observed high mortality associated with Gramnegative or fungal infection.^{2 , 17 , 18} Fungal infection is associated with moderate to severe cerebral palsy, higher risk of developing blindness and deafness, and late neurodevelopment at 18 months of life;¹⁸ 60% of survivors of a fungal infection episode have late neurodevelopment.¹⁹ However, the highest incidence of severe motor deficit in that particular group in the present study was not maintained after the multivariate analysis, possibly due to the small number of patients with proven fungal sepsis (11 preterm infants), and future studies are needed.

The concern in determining the impact of pathogens on neurodevelopment was limited to the number of positive blood cultures and variety of pathogens found. The volume of blood collected for cultures is usually small, which interferes with the sensitivity of these cultures, particularly in early-onset sepsis.²⁰ A limitation of the present study is the lack of an assessment of the inflammatory reaction intensity in each of the infected newborns, in order to determine a possible correlation with late neurodevelopment, as elevated levels of pro-inflammatory cytokines and late neurodevelopment were observed in a previous study.²¹ However, an extremely important aspect of the present study was the assessment of neurodevelopment excluding the VLBW preterm infants with early-onset sepsis, focusing on the outcomes of late-onset sepsis. Early-onset sepsis is closely related to maternal chorioamnionitis, which is related to periventricular leukomalacia, a well described cause of cerebral palsy and cognitive impairment.^{8 , 22}

In this cohort of preterm infants with VLBW, late-onset sepsis was associated with late neurodevelopment; preterm infants with sepsis due to Gram-positive bacteria presented a higher incidence of motor deficit. Care in the neonatal ICU and during follow-up should anticipate therapeutic measures, and the follow-up after hospital discharge should identify early deficits in order to ensure appropriate intervention.

Acknowledgments

The authors would like to thank the statistician Luciano Santos Pinto Guimarães, MsC, for his assistance with the analysis of data; they would also like to thank the pediatrician Ana Claudia W. Benjamin, MD, and the neonatologist Rosanna Nejedlo, MD, for their valuable support in the follow-up of patients.

References

• ¹
  Mwaniki MK, Atieno M, Lawn JE, Newton CR. Long-term neurodevelopmental outcomes after intrauterine and neonatal insults: a systematic review. Lancet. 2012;379:445-52.
• ²
  Adam-Chapman I, Stoll BJ. Neonatal infection and long-term neurodevelopment outcome in the preterm infant. Curr Opin Infect Dis. 2006;19:290-7.
• ³
  Bassler D, Stoll BJ, Schmidt B, Asztalos EV, Roberts RS, Robertson CM, et al. Using a count of neonatal morbidities to predict poor outcome in extremely low birth weight infants: added role of neonatal infection. Pediatrics. 2009;123:313-8.
• ⁴
  Ballot DE, Nana T, Sriruttan C, Cooper PA. Bacterial bloodstream infections in neonates in a developing country. International Scholarly Research Network, ISRN Pediatrics. 2012;2012:508512.
• ⁵
  Downey LC, Smith PB, Benjamin DK. Risk factors and prevention of late-onset sepsis in premature infants. Early Hum Dev. 2012;86:S7-12.
• ⁶
  Lim WH, Lien R, Huang Y, Chiang M, Fu R, Chu S, et al. Prevalence and pathogen distribution of neonatal sepsis among very-low-birth-weight infants. Pediatr Neonatol. 2012;53:228-34.
• ⁷
  Alcântara AP, Sousa FC, Carneiro IC, Meneses J, Miranda MM, Cechinel RB, et al. Critérios nacionais de infecções relacionadas à assistência à saúde: Neonatologia. Manual da Agência Nacional de Vigilância Sanitária. 2010; 1-76. [cited 05 Mar 2013]. Available from: http://portal.anvisa.gov.br/wps/content/Anvisa+Portal/Anvisa/Inicio/Servicos+de+Saude/Assunto+de+Interesse/Aulas+Cursos+Cartazes+Publicacoes+e+Seminarios/Controle+de+Infeccao+em+Servicos+de+Saude/Manuais
  » Available from: http://portal.anvisa.gov.br/wps/content/Anvisa+Portal/Anvisa/Inicio/Servicos+de+Saude/Assunto+de+Interesse/Aulas+Cursos+Cartazes+Publicacoes+e+Seminarios/Controle+de+Infeccao+em+Servicos+de+Saude/Manuais
• ⁸
  Hemels MA, Nijman J, Leemans A, van Kooij BJ, van den Hoogen A, Benders MJ, et al. Cerebral white matter and neurodevelopment of preterm infants after coagulase-negative staphylococcal sepsis. Pediatr Crit Care Med. 2012;13:678-84.
• ⁹
  Ballard JL, Khoury JC, Weding K, Wang L, Eilers-Walsman BL. New Ballard score expanded to include extremely premature infants. J Pediatr (Rio J). 1991;119:417-23.
• ¹⁰
  Alexander GR, Himes JH, Kaufman RB, Mor J, Kogan M. A United States National reference for fetal growth. Obstet Gynecol. 1996;87:163-8.
• ¹¹
  Horbar JD, Carpenter JH, Badger GJ, Kenny MJ, Soll RF, Morrow KA, et al. Mortality and neonatal morbidity among infants 501 to 1500 grams from 2000 to 2009. Pediatrics. 2012;129:1019-26.
• ¹²
  Jobe AH, Bancalari E. Bronchopulmonary dysplasia. Am J Resp Crit Care Med. 2001;163:1723-9.
• ¹³
  Vohr BR, Stephens BE, Higgins RD. Are outcome of extremely preterm infants improving? Impact of Bayley assessment on outcomes J Pediatr (Rio J). 2012;161:222-8.
• ¹⁴
  Stoll BJ, Hansen NI, Adams-Chapman I, Fanaroff AA, Hintz SR, Vohr B, et al. Neurodevelopmental and growth impairment among extremely low-birth-weight infants with neonatal infection. JAMA. 2004;292:2357-65.
• ¹⁵
  Schlapbach JL, Aebischer M, Adams M, Natalucci G, Bonhoeffer J, Latzin P, et al. Impact of sepsis on neurodevelopmental outcome in a Swiss national cohort of extremely premature infants. Pediatrics. 2011;128:e348-57.
• ¹⁶
  Stoll BJ, Hansen N, Fanaroff AA, Wright LL, Carlo WA, Ehrenkranz RA, et al. Late-onset sepsis in very low birth weight neonates: the experience of the NICHD neonatal research network. Pediatrics. 2002;110:285-91.
• ¹⁷
  Friedman S, Richardson SE, Jacobs SE, O' Brien K. Systemic Candida infection in extremely low birth weight infants: short term morbidity and long term neurodevelopmental outcome. Pediatr Infect Dis J. 2000;19:499-504.
• ¹⁸
  Benjamin DK, Stoll BJ, Fanaroff AA, McDonald SA, Oh W, Higgins RD, et al. Neonatal candidiasis among extremely low birth weight infants: risk factors, mortality rates, and neurodevelopmental outcomes at 18 to 22 months. Pediatrics. 2006;117:84-92.
• ¹⁹
  Benjamin DK, Stoll BJ, Gantz MG, Walsh MC, Sánchez PJ, Das A, et al. Neonatal candidiasis: epidemiology, risk factors, and clinical judgment. Pediatrics. 2010;126:e865-73.
• ²⁰
  Schelonka R, Chai M, Yoder B, Hensley D, Ascher D. Volume of blood required to detect common neonatal pathogens. J Pediatr (Rio J). 1996;129:275-8.
• ²¹
  Silveira RC, Procianoy RS. High plasma cytokine levels, white matter injury and neurodevelopment of high risk preterm infants: assessment at two years. Early Hum Dev. 2011;87:433-7.
• ²²
  Wu YW, Colford Jr JM. Chorioamnionitis as a risk factor for cerebral palsy: A meta-analysis. JAMA. 2000;284: 1417-24.

• *
  Study conducted at the Universidade Federal do Rio Grande do Sul and Hospital de Clinicas de Porto Alegre.

Publication Dates

• Publication in this collection
  jan-feb 2014

History

• Received
  05 Apr 2013
• Accepted
  28 May 2013